HuGE Literature Finder
Records
1
-
19
EGF rs4444903 polymorphism is associated with risk of HCV-related cirrhosis and HBV/HCV-related hepatocellular carcinoma. International journal of clinical oncology 2021 Jul . Wang Jia, Zhong Yanlin, Meng Guix |
Genetic Polymorphism of Epidermal Growth Factor Gene as a Predictor of Hepatocellular Carcinoma in Hepatitis C Cirrhotic Patients. Asian Pacific journal of cancer prevention : APJCP 2020 Jul 21 (7): 2047-2053. Baghdadi Ibrahim, Abu Ella Khaled, El Shaaraway Ahmed, Elshayeb Elsayed, El-Rebey Hala S, El Hoseeny Mohamed, Naguib Mary, Nada A |
Hepatocellular Carcinoma Risk Stratification by Genetic Profiling in Patients with Cirrhosis. Seminars in liver disease 2019 Mar . Fujiwara Naoto, Hoshida Yuj |
Polymorphism in the EREG gene confers susceptibility to tuberculosis. BMC medical genetics 2019 Jan 20 (1): 7. Cao Wen, Luo Liu-Lin, Chen Wei-Wei, Liang Li, Zhang Ran-Ran, Zhao Yan-Lin, Chen Jin, Yue J |
Genetic Polymorphism of Epidermal Growth Factor rs4444903 Influences Susceptibility to HCV-Related Liver Cirrhosis and Hepatocellular Carcinoma in a Chinese Han Population. Clinical laboratory 2017 Apr 63 (4): 845-850. Zhang Shitian, Qiao Kunyan, Trieu Congdoanh, Huo Zhixiao, Dai Qinghai, Du Yanan, Lu Wei, Hou W |
Impact of EGF, IL28B, and PNPLA3 polymorphisms on the outcome of allograft hepatitis C: a multicenter study. Clinical transplantation 2016 Feb . Mueller Jessica L, King Lindsay Y, Johnson Kara B, Gao Tian, Nephew Lauren D, Kothari Darshan, Simpson Mary Ann, Zheng Hui, Wei Lan, Corey Kathleen E, Misdraji Joseph, Lee Joon Hyoek, Lin M Valerie, Gogela Neliswa A, Fuchs Bryan C, Tanabe Kenneth K, Gordon Fredric D, Curry Michael P, Chung Raymond |
Quantitative assessment of the effect of epidermal growth factor 61A/G polymorphism on the risk of hepatocellular carcinoma. Oncology letters 2015 Nov 10 (5): 3199-3205. Shen Xian-Feng, Zeng Xian-Tao, Jian Zhi-Yuan, Zhou Meng, Zhou Ping, Zhang M |
Impact of epidermal growth factor single-nucleotide polymorphism on recurrence of hepatocellular carcinoma after hepatectomy in patients with chronic hepatitis C virus infection. Cancer science 2014 Jun 105 (6): 646-50. Yoshiya Shohei, Fujimoto Yukiko, Bekki Yuki, Konishi Hideyuki, Yamashita Yo-Ichi, Ikegami Toru, Yoshizumi Tomoharu, Shirabe Ken, Oda Yoshinao, Maehara Yoshihi |
Association of epidermal growth factor and epidermal growth factor receptor polymorphisms with the risk of hepatitis B virus-related hepatocellular carcinoma in the population of North China. Genetic testing and molecular biomarkers 2013 Aug 17 (8): 595-600. Wu Jia, Zhang Wei, Xu Aiqiang, Zhang Li, Yan Tao, Li Zhuo, Wu Xiaopan, Zhu Xilin, Ma Juan, Li Ke, Li Hui, Liu Yi |
Inhibition of 15-hydroxyprostaglandin dehydrogenase by Helicobacter pylori in human gastric carcinogenesis. Cancer prevention research (Philadelphia, Pa.) 2013 2 6 (4): 349-59. Ryu Yeon-Mi, Myung Seung-Jae, Park Young Soo, Yang Dong-Hoon, Song Ho June, Jeong Jin-Yong, Lee Sun Mi, Song Miyeoun, Kim Do Hoon, Lee Hyo-Jeong, Park Soo-Kyung, Fink Stephen P, Markowitz Sandy D, Jung Kee Wook, Kim Kyung-Jo, Ye Byong Duk, Byeon Jeong-Sik, Jung Hwoon-Yong, Yang Suk-Kyun, Kim Jin- |
Single nucleotide polymorphisms of genes for EGF, TGF-ß and TNF-a in patients with pancreatic carcinoma. Cancer genomics & proteomics 2012 Sep 9 (5): 5. Zhang L, Wu G, Herrle F, Niedergethmann M, Keese M |
Epidermal growth factor gene polymorphism 61A/G in patients with chronic liver disease for early detection of hepatocellular carcinoma: a pilot study. European journal of gastroenterology & hepatology 2012 Apr 24 (4): 458-63. Abbas Emad, Shaker Olfat, Abd El Aziz Ghada, Ramadan Huda, Esmat Gam |
Carriage of the EGF rs4444903 A>G functional polymorphism associates with disease progression in chronic HBV infection. Clinical and experimental immunology 2012 Feb 167 (2): 296-302. Cmet S, Fabris C, Fattovich G, Falleti E, Bitetto D, Cussigh A, Fontanini E, Fornasiere E, Pirisi M, Toniutto |
Association between the epidermal growth factor rs4444903 G/G genotype and advanced fibrosis at a young age in chronic hepatitis C. Cytokine 2011 Nov . Falleti E, Cmet S, Fabris C, Bitetto D, Cussigh A, Fornasiere E, Bignulin E, Feruglio C, Mosanghini E, Fontanini E, Pirisi M, Toniutto P |
Epidermal growth factor +61 G/A polymorphism and the risk of hepatocellular carcinoma in a Chinese population. Genetic testing and molecular biomarkers 2011 Apr 15 (4): 251-5. Chen Kefei, Wei YongGang, Yang HanTeng, Li |
Association between epidermal growth factor 61A/G polymorphism and hepatocellular carcinoma susceptibility in Chinese patients. Liver international : official journal of the International Association for the Study of the Liver 2010 Jan 30 (1): 112-8. Li Yajuan, Xie Qing, Lu Fengmin, Zhao Jingmin, Mao Panyong, Li Zhuo, Liu Shuang, Zhuang H |
No association of EGF 5'UTR variant A61G and hepatocellular carcinoma in Chinese patients with chronic hepatitis B virus infection. Pathology 2009 41 (6): 555-60. Qi Peng, Wang Hao, Chen Yue-Ming, Sun Xiao-Juan, Liu Yan, Gao Chun-Fa |
Genetic variations in humans associated with differences in the course of hepatitis C. Biochemical and biophysical research communications 2004 Apr 317 (2): 335-41. Saito T, Ji G, Shinzawa H, Okumoto K, Hattori E, Adachi T, Takeda T, Sugahara K, Ito JI, Watanabe H, Saito K, Togashi H, Ishii K, Matsuura T, Inageda K, Muramatsu M, Kawata S |
Epidermal growth factor 61 A/G polymorphism and uterine cervical cancer. International journal of gynecological cancer : official journal of the International Gynecological Cancer Society 0 17 (2): 492-6. Kang S, Kim J W, Park N-H, Song Y-S, Park S-Y, Kang S-B, Lee H |
- Page last reviewed:Feb 1, 2023
- Page last updated:Mar 31, 2023
- Content source: